Chad A. Walden

579 total citations
6 papers, 442 citations indexed

About

Chad A. Walden is a scholar working on Oncology, Biomaterials and Molecular Biology. According to data from OpenAlex, Chad A. Walden has authored 6 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Biomaterials and 2 papers in Molecular Biology. Recurrent topics in Chad A. Walden's work include Nanoparticle-Based Drug Delivery (3 papers), Cancer therapeutics and mechanisms (2 papers) and Gold and Silver Nanoparticles Synthesis and Applications (2 papers). Chad A. Walden is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Cancer therapeutics and mechanisms (2 papers) and Gold and Silver Nanoparticles Synthesis and Applications (2 papers). Chad A. Walden collaborates with scholars based in United States. Chad A. Walden's co-authors include Joel M. Reid, J. David Robertson, Priyabrata Mukherjee, Resham Bhattacharya, Karuna Giri, Daniel F. Moyano, Vincent M. Rotello, Rochelle R. Arvizo, Oscar R. Miranda and Rachel A. Kudgus and has published in prestigious journals such as PLoS ONE, Scientific Reports and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Chad A. Walden

6 papers receiving 437 citations

Peers

Chad A. Walden
Neelima Gupta India
Soo Ah Park South Korea
Christopher D. Sarsons Canada
Hayley Nehoff New Zealand
Elisa DeStanchina United States
Vertika Pathak Germany
Hari Krishna Sajja United States
Charlene M. Dawidczyk United States
Gee Young Lee United States
Chandra Kumar Elechalawar United States
Neelima Gupta India
Chad A. Walden
Citations per year, relative to Chad A. Walden Chad A. Walden (= 1×) peers Neelima Gupta

Countries citing papers authored by Chad A. Walden

Since Specialization
Citations

This map shows the geographic impact of Chad A. Walden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad A. Walden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad A. Walden more than expected).

Fields of papers citing papers by Chad A. Walden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad A. Walden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad A. Walden. The network helps show where Chad A. Walden may publish in the future.

Co-authorship network of co-authors of Chad A. Walden

This figure shows the co-authorship network connecting the top 25 collaborators of Chad A. Walden. A scholar is included among the top collaborators of Chad A. Walden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chad A. Walden. Chad A. Walden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Reid, Joel M., Matthew P. Goetz, Sarah A. Buhrow, et al.. (2014). Pharmacokinetics of endoxifen and tamoxifen in female mice: implications for comparative in vivo activity studies. Cancer Chemotherapy and Pharmacology. 74(6). 1271–1278. 34 indexed citations
2.
Kudgus, Rachel A., Chad A. Walden, Renee M. McGovern, et al.. (2014). Tuning Pharmacokinetics and Biodistribution of a Targeted Drug Delivery System Through Incorporation of a Passive Targeting Component. Scientific Reports. 4(1). 5669–5669. 40 indexed citations
3.
Davis, Mark M., Deborah I. Bunin, Steven J. Samuelsson, et al.. (2014). Characterization of Batracylin-induced Renal and Bladder Toxicity in Rats. Toxicologic Pathology. 43(4). 519–529. 5 indexed citations
4.
Kudgus, Rachel A., Annamária Szabolcs, Jameel Ahmad Khan, et al.. (2013). Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics. PLoS ONE. 8(3). e57522–e57522. 25 indexed citations
5.
Reid, Joel M., Chad A. Walden, Rui Qin, et al.. (2011). Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668. Cancer Prevention Research. 4(3). 347–353. 16 indexed citations
6.
Arvizo, Rochelle R., Oscar R. Miranda, Daniel F. Moyano, et al.. (2011). Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles. PLoS ONE. 6(9). e24374–e24374. 322 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neelima Gupta Breakdown of academic impact, for papers by Soo Ah Park Breakdown of academic impact, for papers by Christopher D. Sarsons Breakdown of academic impact, for papers by Hayley Nehoff Breakdown of academic impact, for papers by Elisa DeStanchina Breakdown of academic impact, for papers by Vertika Pathak Breakdown of academic impact, for papers by Hari Krishna Sajja Breakdown of academic impact, for papers by Charlene M. Dawidczyk Breakdown of academic impact, for papers by Gee Young Lee Breakdown of academic impact, for papers by Chandra Kumar Elechalawar
Rankless by CCL
2026